Print

Proteostasis Therapeutics, Inc. Presents Data at 11th International Conference on Alzheimer’s and Parkinson’s Diseases  
3/8/2013 8:41:01 AM

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, today presented data supporting the Company’s protein clearance program in a poster titled “Developing Usp14 Inhibitors as Disease-Modifying Therapeutics for Protein Aggregation Diseases” at the 11th International Conference on Alzheimer’s and Parkinson’s Diseases in Florence, Italy.
//-->